Innovage Holding CORP Form 4 insider transactions

NASDAQ
InnovAge Holding Corp. Director Richard C. Zoretic has significantly increased his direct beneficial ownership in the company through a series of common stock purchases totaling 42,715 shares over three days in late May 2025.
NASDAQ
InnovAge Holding Corp. Director Richard C. Zoretic has significantly increased his beneficial ownership in the company by acquiring 3,045 shares of common stock through open market purchases over three consecutive days in May 2025.
NASDAQ
Director Richard C. Zoretic increased his holdings in InnovAge Holding Corp. through multiple open market purchases.
NASDAQ
Michael Scarbrough, President and COO of InnovAge Holding Corp., recently purchased a total of 33,000 shares of the company's common stock in a series of transactions.
NASDAQ
CEO Patrick Blair reports a transaction involving InnovAge Holding Corp. stock to cover tax obligations related to vesting restricted stock units.
NASDAQ
InnovAge Holding Corp.'s CEO, Patrick Blair, sold 5,053 shares of common stock to cover tax obligations related to vesting restricted stock units.
NASDAQ
Nicole D'Amato, Chief Legal Officer of InnovAge Holding Corp., sold 1,660 shares of common stock at an average price of $6.54 on November 6, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Nicole D'Amato, Chief Legal Officer of InnovAge Holding Corp., sold a portion of her shares under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Director James G. Carlson receives 13,334 shares of InnovAge Holding Corp. stock as compensation for his service in fiscal year 2024.
NASDAQ
Director Richard C Zoretic reports acquiring and disposing of InnovAge Holding Corp. shares on September 5, 2024.
NASDAQ
Director John Ellis Bush acquired 19,841 shares of InnovAge Holding Corp. on September 5, 2024, through the vesting of restricted stock units.
NASDAQ
Director Marilyn B Tavenner acquired 19,841 Restricted Stock Units (RSUs) of InnovAge Holding Corp. on September 5, 2024, which will vest on July 1, 2025, subject to continued service.
NASDAQ
Director Kennedy Edward Moore Jr. reports acquiring 19,841 shares of InnovAge Holding Corp. and disposing of shares on September 5, 2024.
NASDAQ
InnovAge Holding Corp.'s CEO, Patrick T. Blair, disposed of 5,053 shares of common stock on September 1, 2024, to satisfy tax obligations related to the vesting of restricted stock units.
NASDAQ
Director Teresa Sparks reports acquisition of InnovAge Holding Corp. shares and changes in beneficial ownership.
NASDAQ
Director James G. Carlson of InnovAge Holding Corp. reports acquiring and disposing of common stock and holding restricted stock units.
NASDAQ
Director Patricia Fontneau reports acquiring and disposing of InnovAge Holding Corp. common stock and acquiring Restricted Stock Units (RSUs).
NASDAQ
Nicole D'Amato, Chief Legal Officer of InnovAge Holding Corp., reports a transaction involving the withholding of shares to cover tax obligations related to vested restricted stock units.
NASDAQ
Richard Feifer, Chief Medical Officer of InnovAge Holding Corp., sold 14,303 shares of common stock on August 15, 2024, to cover tax obligations related to vesting restricted stock units.
NASDAQ
Nicole D'Amato, Chief Legal Officer of InnovAge Holding Corp., sold 7,486 shares of common stock to cover tax obligations related to the vesting of restricted stock units.
NASDAQ
InnovAge Holding Corp.'s CEO, Patrick Blair, disposed of shares to cover tax obligations related to the vesting of restricted stock units.
NASDAQ
Nicole D'Amato, Chief Legal Officer of InnovAge Holding Corp., reports the disposition of shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
Richard Feifer, Chief Medical Officer of InnovAge Holding Corp., reports disposition of shares to cover tax obligations.
NASDAQ
Christine Bent, Chief Operations Officer of InnovAge Holding Corp., reports a transaction involving the withholding of shares to cover tax obligations.
NASDAQ
Patrick T. Blair, President and CEO of InnovAge Holding Corp., reports acquiring and disposing of common stock on June 5, 2024.
NASDAQ
Chief Medical Officer Richard Feifer reports acquisition and disposal of InnovAge Holding Corp. stock.
NASDAQ
Nicole D'Amato, Chief Legal Officer of InnovAge Holding Corp., reports the acquisition of 97,403 shares of common stock and the disposal of 275,012 shares on June 4, 2024.
NASDAQ
Christine Bent, Chief Operations Officer of InnovAge Holding Corp., reports acquisition and disposal of company stock, including restricted stock units.
NASDAQ
InnovAge Holding Corp.'s CEO, Patrick Blair, disposed of 3,321 shares of common stock on June 1, 2024, to cover tax obligations related to the vesting of restricted stock units.
NASDAQ
Christine Bent, Chief Operations Officer of InnovAge Holding Corp., reports a transaction involving the withholding of shares to cover tax obligations related to vested restricted stock units.